News Image

Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan

Provided By GlobeNewswire

Last update: May 14, 2024

– Prostate segmentation using a deep learning convolutional neural network –

– Model uses 24,611,072 parameters extracted from 7,466 training images –

Read more at globenewswire.com

PROFOUND MEDICAL CORP

NASDAQ:PROF (3/7/2025, 8:00:01 PM)

6.86

-0.43 (-5.9%)



Find more stocks in the Stock Screener

Follow ChartMill for more